Get the latest news on Centogene stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on CNTGF performance

Latest Centogene Stock News | OTC:CNTGF | Benzinga

Centogene NV is a United States-based company engaged in data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. The company operates in two segments: pharmaceutical and diagnostics. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its diagnostics segment provides targeted genetic sequencing and diagnostics services to patients. Its geographic regions are Europe, the Middle East, North America, and Latin America.

Centogene NV

Press Releases

CENTOGENE Data on Novel Genetic Risk Factor for Parkinson's Disease in The Lancet Neurology

CENTOGENE Signs Strategic Transaction With Private Equity Group Charme Capital Partners

CENTOGENE Announces Voting Results of Extraordinary General Meeting

CENTOGENE Closes Strategic Transaction with Private Equity Group Charme Capital Partners

CNTG

CNTGF

Centogene

Comments

Centogene Stock News

News

Latest Centogene Stock News | OTC:CNTGF | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga